Back to search
Atopic Dermatitis of Adults
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atopic Dermatitis of Adults trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Atopic Dermatitis of Adults trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic…
This is a Phase 1, randomized, blinded, placebo controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study of BBT001 in healthy volunteers…
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance…
This double-blind, placebo-controlled study is designed to evaluate the safety and efficacy of ENV-294 in adults with moderate-to-severe atopic dermatitis (AD).…
The purpose of this study is to find out how well tilrekimig works, how safe it is, and how it affects the body when used together with medicated creams or oint…
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Upadacitinib is an approved drug for treating AD.…